Hearing Therapy Pioneer Auris Medical Gets $50 Million Series C Financing
This article was originally published in The Pink Sheet Daily
Executive Summary
Auris Medical AG has completed Europe’s largest biotech investing round so far this year, led by Sofinnova Partners and Sofinnova Ventures, and hopes to advance the development of new otologic drugs for hearing dysfunction.